Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations

A. Chakrabarti (South San Francisco, United States of America), D. Choy (South San Francisco, United States of America), X. Yang (South San Francisco, United States of America), Y. Cao (South San Francisco, United States of America), W. Tew (South San Francisco, United States of America), J. Mar (South San Francisco, United States of America), N. Rathore (South San Francisco, United States of America), O. Li (South San Francisco, United States of America), M. Grimbaldeston (South San Francisco, United States of America), C. Brightling (Leicester, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Rosenberger (South San Francisco, United States of America)

Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Session: Phenotypes of asthma and COPD
Session type: E-poster session
Number: 1101
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Chakrabarti (South San Francisco, United States of America), D. Choy (South San Francisco, United States of America), X. Yang (South San Francisco, United States of America), Y. Cao (South San Francisco, United States of America), W. Tew (South San Francisco, United States of America), J. Mar (South San Francisco, United States of America), N. Rathore (South San Francisco, United States of America), O. Li (South San Francisco, United States of America), M. Grimbaldeston (South San Francisco, United States of America), C. Brightling (Leicester, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Rosenberger (South San Francisco, United States of America). Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations. 1101

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Plasma biomarkers and response to therapy at exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007

Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Sputum biomarkers in COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Visfatin as a possible serum biomarker in COPD
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019


Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005


Procalcitonin use in acute exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011


Our experience of procalcitonin assay in identifying bacterial COPD exacerbations
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011

Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Serum Club cell16 levels as a biomarker in tobacco-smoke COPD and biomass-smoke COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


IgG4 as a potential biomarker of acute exacerbations in ILD
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017


Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009